
Keywords: ATM; ataxia telangiectasia mutated; DDR; DNA-damage response; MAPK; mitogen-activated protein kinase; MMP; matrix metalloproteinase; mTOR; mammalian target of rapamycin; PKD1; protein kinase D1; SASP; senescence-associated secretory phenotype; SCC; squamo